Investing.com - Alpha Tau Medical reported on Tuesday third quarter earnings that beat analysts' forecasts and revenue that was inline with expectations.
Alpha Tau Medical announced earnings per share of $-0.040 on revenue of $0.00. Analysts polled by Investing.com anticipated EPS of $-0.116 on revenue of $0.00.
Alpha Tau Medical shares are down 61% from the beginning of the year and are trading at $3.750 , down-from-52-week-high.
Alpha Tau Medical follows other major Healthcare sector earnings this month
Alpha Tau Medical's report follows an earnings beat by Eli Lilly on November 1, who reported EPS of $1.98 on revenue of $6.94B, compared to forecasts EPS of $1.91 on revenue of $6.91B.
AbbVie had beat expectations on October 28 with third quarter EPS of $3.66 on revenue of $14.81B, compared to forecast for EPS of $3.58 on revenue of $14.93B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar